戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 249234作成日:2026年10月26日

Cholesterol → Epirubicin Hydrochloride

https://huagongshe.com/reaction/249234

反応式

関与物質

役割名称HCID仕込み量
反応物CholesterolHCID 5997—
反応物ChloroformHCID 6212—
反応物EpirubicinHCID 41867—
反応物[3-[hydroxy-[2-[[4-(2-methoxyethoxy)-4-oxobutanoyl]amino]ethoxy]phosphoryl]oxy-2-[(E)-octadec-9-enoyl]oxypropyl] (E)-octadec-9-enoateHCID 6440842—
生成物Epirubicin HydrochlorideHCID 65348—
生成物Doxorubicin HydrochlorideHCID 443939—

反応手順

Vesicle-forming lipids containing PEG-PE, PG, PHEPC, and cholesterol and α-TC in a mole ratio of 0.15: 0.3: 1.85: 1: 0.2 were dissolved in chloroform to a final lipid concentration of 25 μmol phospholipid/ml. The lipid mixture was dried into a thin film under reduced pressure. The film was hydrated with a solution of 0.125 M ammonium sulfate to form MLVs. The MLV suspension was frozen in a dry ice acetone bath and thawed three times and sized to 80-100 nm by extrusion as detailed above. An ammonium ion gradient was created substantially as described in Example 10. The liposomes were loaded with epirubicin, and free (unbound drug) removed also as described in Example 10 for doxorubicin. The final concentration of entrapped drug was about 50-100 μg drug/μmol lipid. Epirubicin HCl and doxorubicin HCL, the commercial products, were obtained from the hospital pharmacy.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05213804
出典データセットuspto-grants-1993_05
ORD IDord-a8c09ad378a649a4bf286246ad752077
出典メモuspto-grants-1993_05